Skip to main content
. 2023 Feb 19;15(4):1326. doi: 10.3390/cancers15041326

Figure 1.

Figure 1

Survival analysis according to histology, tumor type, and gender. According to histology, LAMN patients (vs HAMN patients) showed significantly improved OS (106.45 vs. 61.15 months, p < 0.0001, (A) and PFS (90.63 vs. 40.52 months, p < 0.0001), (B)). There was no significant difference neither regarding OS (105.92 vs. 99.42 months, p = 0.8290, (C) nor PFS (93.23 vs. 74.22 months, p = 0.2840), (D)) between patients with primary vs. relapsed LAMN tumors. Female LAMN patients exhibited significantly improved OS and PFS compared to male patients (OS: 110.47 vs. 96.08 months, p = 0.0337, (E); PFS: 99.41 vs. 76.51 months, p = 0.0059, (F)). Months for OS and PFS are described as means.